Literature DB >> 19253386

Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer's disease.

Ryan Chamberlain1, Denise Reyes, Geoffrey L Curran, Malgorzata Marjanska, Thomas M Wengenack, Joseph F Poduslo, Michael Garwood, Clifford R Jack.   

Abstract

One of the hallmark pathologies of Alzheimer's disease (AD) is amyloid plaque deposition. Plaques appear hypointense on T(2)-weighted and T(2)*-weighted MR images probably due to the presence of endogenous iron, but no quantitative comparison of various imaging techniques has been reported. We estimated the T(1), T(2), T(2)*, and proton density values of cortical plaques and normal cortical tissue and analyzed the plaque contrast generated by a collection of T(2)-weighted, T(2)*-weighted, and susceptibility-weighted imaging (SWI) methods in ex vivo transgenic mouse specimens. The proton density and T(1) values were similar for both cortical plaques and normal cortical tissue. The T(2) and T(2)* values were similar in cortical plaques, which indicates that the iron content of cortical plaques may not be as large as previously thought. Ex vivo plaque contrast was increased compared to a previously reported spin-echo sequence by summing multiple echoes and by performing SWI; however, gradient echo and SWI were found to be impractical for in vivo imaging due to susceptibility interface-related signal loss in the cortex. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19253386      PMCID: PMC2743236          DOI: 10.1002/mrm.21951

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  24 in total

1.  The loss of small objects in variable TE imaging: implications for FSE, RARE, and EPI.

Authors:  R T Constable; J C Gore
Journal:  Magn Reson Med       Date:  1992-11       Impact factor: 4.668

2.  Susceptibility weighted imaging (SWI).

Authors:  E Mark Haacke; Yingbiao Xu; Yu-Chung N Cheng; Jürgen R Reichenbach
Journal:  Magn Reson Med       Date:  2004-09       Impact factor: 4.668

3.  Contrast, resolution, and detectability in MR imaging.

Authors:  R T Constable; R M Henkelman
Journal:  J Comput Assist Tomogr       Date:  1991 Mar-Apr       Impact factor: 1.826

4.  Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy.

Authors:  H Benveniste; G Einstein; K R Kim; C Hulette; G A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents.

Authors:  Sang-Pil Lee; Maria F Falangola; Ralph A Nixon; Karen Duff; Joseph A Helpern
Journal:  Magn Reson Med       Date:  2004-09       Impact factor: 4.668

6.  Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging.

Authors:  Jiangyang Zhang; Paul Yarowsky; Marcia N Gordon; Giovanni Di Carlo; Sanjay Munireddy; Peter C M van Zijl; Susumu Mori
Journal:  Magn Reson Med       Date:  2004-03       Impact factor: 4.668

Review 7.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

8.  Automatic, localized in vivo adjustment of all first- and second-order shim coils.

Authors:  R Gruetter
Journal:  Magn Reson Med       Date:  1993-06       Impact factor: 4.668

9.  MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease.

Authors:  Joseph A Helpern; Sang-Pil Lee; Maria F Falangola; Victor V Dyakin; Adam Bogart; Babak Ardekani; Karen Duff; Craig Branch; Thomas Wisniewski; Mony J de Leon; Oliver Wolf; Jacqueline O'Shea; Ralph A Nixon
Journal:  Magn Reson Med       Date:  2004-04       Impact factor: 4.668

10.  Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.

Authors:  Marc Dhenain; Nadine El Tannir El Tayara; Ting-Di Wu; Maryvonne Guégan; Andreas Volk; Carmen Quintana; Benoît Delatour
Journal:  Neurobiol Aging       Date:  2007-06-27       Impact factor: 4.673

View more
  21 in total

1.  Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain.

Authors:  T M Wengenack; D A Reyes; G L Curran; B J Borowski; J Lin; G M Preboske; S S Holasek; E J Gilles; R Chamberlain; M Marjanska; C R Jack; M Garwood; J F Poduslo
Journal:  Neuroimage       Date:  2010-08-20       Impact factor: 6.556

Review 2.  Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.

Authors:  Houshang Amiri; Kolsoum Saeidi; Parvin Borhani; Arash Manafirad; Mahdi Ghavami; Valerio Zerbi
Journal:  ACS Chem Neurosci       Date:  2013-09-26       Impact factor: 4.418

3.  Magnetic resonance imaging of amyloid plaques in transgenic mouse models of Alzheimer's disease.

Authors:  Ryan Chamberlain; Thomas M Wengenack; Joseph F Poduslo; Michael Garwood; Clifford R Jack
Journal:  Curr Med Imaging Rev       Date:  2011-02

Review 4.  MRI in rodent models of brain disorders.

Authors:  Aleksandar Denic; Slobodan I Macura; Prasanna Mishra; Jeffrey D Gamez; Moses Rodriguez; Istvan Pirko
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

5.  Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-κB concomitantly lower Alzheimer's disease plaque formation and microglial activation in AβPP/PS-1 transgenic mouse brain.

Authors:  Nathan O Solberg; Ryan Chamberlin; Jenette R Vigil; Lorraine M Deck; John E Heidrich; David C Brown; Christina I Brady; Thomas A Vander Jagt; Michael Garwood; Marco Bisoffi; Virginia Severns; David L Vander Jagt; Laurel O Sillerud
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

6.  In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.

Authors:  Yue Zhao; Marcus E Raichle; Jie Wen; Tammie L Benzinger; Anne M Fagan; Jason Hassenstab; Andrei G Vlassenko; Jie Luo; Nigel J Cairns; Jon J Christensen; John C Morris; Dmitriy A Yablonskiy
Journal:  Neuroimage       Date:  2016-12-15       Impact factor: 6.556

7.  Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging.

Authors:  Jing Yang; Youssef Zaim Wadghiri; Dung Minh Hoang; Wai Tsui; Yanjie Sun; Erika Chung; Yongsheng Li; Andrew Wang; Mony de Leon; Thomas Wisniewski
Journal:  Neuroimage       Date:  2011-01-19       Impact factor: 6.556

8.  SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.

Authors:  Laurel O Sillerud; Nathan O Solberg; Ryan Chamberlain; Robert A Orlando; John E Heidrich; David C Brown; Christina I Brady; Thomas A Vander Jagt; Michael Garwood; David L Vander Jagt
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  In vivo imaging biomarkers in mouse models of Alzheimer's disease: are we lost in translation or breaking through?

Authors:  Benoît Delatour; Stéphane Epelbaum; Alexandra Petiet; Marc Dhenain
Journal:  Int J Alzheimers Dis       Date:  2010-09-30

Review 10.  Bioavailable Trace Metals in Neurological Diseases.

Authors:  Aurélia Poujois; Jean-Christophe Devedjian; Caroline Moreau; David Devos; Pascal Chaine; France Woimant; James A Duce
Journal:  Curr Treat Options Neurol       Date:  2016-10       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.